Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy

Nanotheranostics, an amalgamation of therapeutic and diagnostic capabilities at the nanoscale, is revolutionizing personalized medicine. Polymer-drug conjugates (PDCs) stand at the forefront of this arena, offering a multifaceted approach to treat complex diseases such as cancer. This review explore...

Full description

Saved in:
Bibliographic Details
Published in:Discover. Oncology 2024-11, Vol.15 (1), p.641-21, Article 641
Main Authors: Parashar, Ashish Kumar, Saraogi, Gaurav Kant, Jain, Pushpendra Kumar, Kurmi, Balakdas, Shrivastava, Vivek, Arora, Vandana
Format: Article
Language:English
Subjects:
Acids
Biodistribution
Brain cancer
Breast cancer
Cancer Research
Cancer therapies
Chemical bonds
Contrast agents
Drug delivery systems
Imaging agents
Integrated approach
Internal Medicine
Medicine
Medicine & Public Health
Molecular Medicine
Nanomedicine
Nanoparticles
Nanotheranostics
Oncology
Pancreatic cancer
Polyethylene glycol
Polymer-drug conjugates
Polymerization
Polymers
Precision medicine
Quantum dots
Radiotherapy
Review
Rheumatoid arthritis
Side effects
Surgical Oncology
Targeted drug delivery
Tomography
Vitamin B
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c422t-5385c6632e50b582dc20a8f5aa3313d6e16c2cd6fa2e2bb1289e24255de8fd6a3
container_end_page 21
container_issue 1
container_start_page 641
container_title Discover. Oncology
container_volume 15
creator Parashar, Ashish Kumar
Saraogi, Gaurav Kant
Jain, Pushpendra Kumar
Kurmi, Balakdas
Shrivastava, Vivek
Arora, Vandana
description Nanotheranostics, an amalgamation of therapeutic and diagnostic capabilities at the nanoscale, is revolutionizing personalized medicine. Polymer-drug conjugates (PDCs) stand at the forefront of this arena, offering a multifaceted approach to treat complex diseases such as cancer. This review explores the recent advancements in PDCs, highlighting their design principles, working mechanisms, and the therapeutic applications. We discuss the incorporation of imaging agents into PDCs that allow for real-time monitoring of drug delivery and treatment efficacy. With the aim of improving patient care, the review examines how PDCs enable targeted drug delivery, minimize side effects, and provide valuable diagnostic data, hence enhancing the precision of medical interventions. We also address the challenges facing the clinical translation of PDCs, such as scalability, regulatory hurdles, and cost-effectiveness, providing a comprehensive outlook on the future of nanotheranostics in patient management.
doi_str_mv 10.1007/s12672-024-01509-9
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8d5e526acefc487d87679755aee1f945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8d5e526acefc487d87679755aee1f945</doaj_id><sourcerecordid>3126813773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-5385c6632e50b582dc20a8f5aa3313d6e16c2cd6fa2e2bb1289e24255de8fd6a3</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEolXpH-CAInHhErDH8Ue4IFRRqFSJHsqBk-W1J6lXWXuxk0rLr693U0rLgdNYM-88nrHfqnpNyXtKiPyQKQgJDYG2IZSTrumeVccgGWkEofT5o_NRdZrzmhACnDJG-MvqiHUcJJXsuPp5FcfdBlPj0jzUNob1PJgJ88c64W0c58nH4H_7MNTBhDjdYCohT97WZsAw5bqPqXbeDCXrc22Cqw-i7e5V9aI3Y8bT-3hS_Tj_cn32rbn8_vXi7PNlY1uAqeFMcSsEA-RkxRU4C8SonhvDGGVOIBUWrBO9AYTVioLqEFrg3KHqnTDspLpYuC6atd4mvzFpp6Px-pCIadAmlYFH1Mpx5CCMxd62Sjolhewk5waR9l3LC-vTwtrOqw06WzZMZnwCfVoJ_kYP8VZTynnbKVYI7-4JKf6aMU9647PFcTQB45w1KwvItmsFFOnbf6TrOKdQ3mqvEooyKfdAWFQ2xZwT9g_TUKL3TtCLE3Rxgj44QXel6c3jPR5a_vx7EbBFkEspDJj-3v0f7B3jZ8AC</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3126813773</pqid></control><display><type>article</type><title>Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Parashar, Ashish Kumar ; Saraogi, Gaurav Kant ; Jain, Pushpendra Kumar ; Kurmi, Balakdas ; Shrivastava, Vivek ; Arora, Vandana</creator><creatorcontrib>Parashar, Ashish Kumar ; Saraogi, Gaurav Kant ; Jain, Pushpendra Kumar ; Kurmi, Balakdas ; Shrivastava, Vivek ; Arora, Vandana</creatorcontrib><description>Nanotheranostics, an amalgamation of therapeutic and diagnostic capabilities at the nanoscale, is revolutionizing personalized medicine. Polymer-drug conjugates (PDCs) stand at the forefront of this arena, offering a multifaceted approach to treat complex diseases such as cancer. This review explores the recent advancements in PDCs, highlighting their design principles, working mechanisms, and the therapeutic applications. We discuss the incorporation of imaging agents into PDCs that allow for real-time monitoring of drug delivery and treatment efficacy. With the aim of improving patient care, the review examines how PDCs enable targeted drug delivery, minimize side effects, and provide valuable diagnostic data, hence enhancing the precision of medical interventions. We also address the challenges facing the clinical translation of PDCs, such as scalability, regulatory hurdles, and cost-effectiveness, providing a comprehensive outlook on the future of nanotheranostics in patient management.</description><identifier>ISSN: 2730-6011</identifier><identifier>EISSN: 2730-6011</identifier><identifier>DOI: 10.1007/s12672-024-01509-9</identifier><identifier>PMID: 39527173</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acids ; Biodistribution ; Brain cancer ; Breast cancer ; Cancer Research ; Cancer therapies ; Chemical bonds ; Contrast agents ; Drug delivery systems ; Imaging agents ; Integrated approach ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Molecular Medicine ; Nanomedicine ; Nanoparticles ; Nanotheranostics ; Oncology ; Pancreatic cancer ; Polyethylene glycol ; Polymer-drug conjugates ; Polymerization ; Polymers ; Precision medicine ; Quantum dots ; Radiotherapy ; Review ; Rheumatoid arthritis ; Side effects ; Surgical Oncology ; Targeted drug delivery ; Tomography ; Vitamin B</subject><ispartof>Discover. Oncology, 2024-11, Vol.15 (1), p.641-21, Article 641</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c422t-5385c6632e50b582dc20a8f5aa3313d6e16c2cd6fa2e2bb1289e24255de8fd6a3</cites><orcidid>0000-0003-4861-2594</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3126813773/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3126813773?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39527173$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Parashar, Ashish Kumar</creatorcontrib><creatorcontrib>Saraogi, Gaurav Kant</creatorcontrib><creatorcontrib>Jain, Pushpendra Kumar</creatorcontrib><creatorcontrib>Kurmi, Balakdas</creatorcontrib><creatorcontrib>Shrivastava, Vivek</creatorcontrib><creatorcontrib>Arora, Vandana</creatorcontrib><title>Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy</title><title>Discover. Oncology</title><addtitle>Discov Onc</addtitle><addtitle>Discov Oncol</addtitle><description>Nanotheranostics, an amalgamation of therapeutic and diagnostic capabilities at the nanoscale, is revolutionizing personalized medicine. Polymer-drug conjugates (PDCs) stand at the forefront of this arena, offering a multifaceted approach to treat complex diseases such as cancer. This review explores the recent advancements in PDCs, highlighting their design principles, working mechanisms, and the therapeutic applications. We discuss the incorporation of imaging agents into PDCs that allow for real-time monitoring of drug delivery and treatment efficacy. With the aim of improving patient care, the review examines how PDCs enable targeted drug delivery, minimize side effects, and provide valuable diagnostic data, hence enhancing the precision of medical interventions. We also address the challenges facing the clinical translation of PDCs, such as scalability, regulatory hurdles, and cost-effectiveness, providing a comprehensive outlook on the future of nanotheranostics in patient management.</description><subject>Acids</subject><subject>Biodistribution</subject><subject>Brain cancer</subject><subject>Breast cancer</subject><subject>Cancer Research</subject><subject>Cancer therapies</subject><subject>Chemical bonds</subject><subject>Contrast agents</subject><subject>Drug delivery systems</subject><subject>Imaging agents</subject><subject>Integrated approach</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Molecular Medicine</subject><subject>Nanomedicine</subject><subject>Nanoparticles</subject><subject>Nanotheranostics</subject><subject>Oncology</subject><subject>Pancreatic cancer</subject><subject>Polyethylene glycol</subject><subject>Polymer-drug conjugates</subject><subject>Polymerization</subject><subject>Polymers</subject><subject>Precision medicine</subject><subject>Quantum dots</subject><subject>Radiotherapy</subject><subject>Review</subject><subject>Rheumatoid arthritis</subject><subject>Side effects</subject><subject>Surgical Oncology</subject><subject>Targeted drug delivery</subject><subject>Tomography</subject><subject>Vitamin B</subject><issn>2730-6011</issn><issn>2730-6011</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk1v1DAQhiMEolXpH-CAInHhErDH8Ue4IFRRqFSJHsqBk-W1J6lXWXuxk0rLr693U0rLgdNYM-88nrHfqnpNyXtKiPyQKQgJDYG2IZSTrumeVccgGWkEofT5o_NRdZrzmhACnDJG-MvqiHUcJJXsuPp5FcfdBlPj0jzUNob1PJgJ88c64W0c58nH4H_7MNTBhDjdYCohT97WZsAw5bqPqXbeDCXrc22Cqw-i7e5V9aI3Y8bT-3hS_Tj_cn32rbn8_vXi7PNlY1uAqeFMcSsEA-RkxRU4C8SonhvDGGVOIBUWrBO9AYTVioLqEFrg3KHqnTDspLpYuC6atd4mvzFpp6Px-pCIadAmlYFH1Mpx5CCMxd62Sjolhewk5waR9l3LC-vTwtrOqw06WzZMZnwCfVoJ_kYP8VZTynnbKVYI7-4JKf6aMU9647PFcTQB45w1KwvItmsFFOnbf6TrOKdQ3mqvEooyKfdAWFQ2xZwT9g_TUKL3TtCLE3Rxgj44QXel6c3jPR5a_vx7EbBFkEspDJj-3v0f7B3jZ8AC</recordid><startdate>20241111</startdate><enddate>20241111</enddate><creator>Parashar, Ashish Kumar</creator><creator>Saraogi, Gaurav Kant</creator><creator>Jain, Pushpendra Kumar</creator><creator>Kurmi, Balakdas</creator><creator>Shrivastava, Vivek</creator><creator>Arora, Vandana</creator><general>Springer US</general><general>Springer Nature B.V</general><general>Springer</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4861-2594</orcidid></search><sort><creationdate>20241111</creationdate><title>Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy</title><author>Parashar, Ashish Kumar ; Saraogi, Gaurav Kant ; Jain, Pushpendra Kumar ; Kurmi, Balakdas ; Shrivastava, Vivek ; Arora, Vandana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-5385c6632e50b582dc20a8f5aa3313d6e16c2cd6fa2e2bb1289e24255de8fd6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acids</topic><topic>Biodistribution</topic><topic>Brain cancer</topic><topic>Breast cancer</topic><topic>Cancer Research</topic><topic>Cancer therapies</topic><topic>Chemical bonds</topic><topic>Contrast agents</topic><topic>Drug delivery systems</topic><topic>Imaging agents</topic><topic>Integrated approach</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Molecular Medicine</topic><topic>Nanomedicine</topic><topic>Nanoparticles</topic><topic>Nanotheranostics</topic><topic>Oncology</topic><topic>Pancreatic cancer</topic><topic>Polyethylene glycol</topic><topic>Polymer-drug conjugates</topic><topic>Polymerization</topic><topic>Polymers</topic><topic>Precision medicine</topic><topic>Quantum dots</topic><topic>Radiotherapy</topic><topic>Review</topic><topic>Rheumatoid arthritis</topic><topic>Side effects</topic><topic>Surgical Oncology</topic><topic>Targeted drug delivery</topic><topic>Tomography</topic><topic>Vitamin B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Parashar, Ashish Kumar</creatorcontrib><creatorcontrib>Saraogi, Gaurav Kant</creatorcontrib><creatorcontrib>Jain, Pushpendra Kumar</creatorcontrib><creatorcontrib>Kurmi, Balakdas</creatorcontrib><creatorcontrib>Shrivastava, Vivek</creatorcontrib><creatorcontrib>Arora, Vandana</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Discover. Oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parashar, Ashish Kumar</au><au>Saraogi, Gaurav Kant</au><au>Jain, Pushpendra Kumar</au><au>Kurmi, Balakdas</au><au>Shrivastava, Vivek</au><au>Arora, Vandana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy</atitle><jtitle>Discover. Oncology</jtitle><stitle>Discov Onc</stitle><addtitle>Discov Oncol</addtitle><date>2024-11-11</date><risdate>2024</risdate><volume>15</volume><issue>1</issue><spage>641</spage><epage>21</epage><pages>641-21</pages><artnum>641</artnum><issn>2730-6011</issn><eissn>2730-6011</eissn><abstract>Nanotheranostics, an amalgamation of therapeutic and diagnostic capabilities at the nanoscale, is revolutionizing personalized medicine. Polymer-drug conjugates (PDCs) stand at the forefront of this arena, offering a multifaceted approach to treat complex diseases such as cancer. This review explores the recent advancements in PDCs, highlighting their design principles, working mechanisms, and the therapeutic applications. We discuss the incorporation of imaging agents into PDCs that allow for real-time monitoring of drug delivery and treatment efficacy. With the aim of improving patient care, the review examines how PDCs enable targeted drug delivery, minimize side effects, and provide valuable diagnostic data, hence enhancing the precision of medical interventions. We also address the challenges facing the clinical translation of PDCs, such as scalability, regulatory hurdles, and cost-effectiveness, providing a comprehensive outlook on the future of nanotheranostics in patient management.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>39527173</pmid><doi>10.1007/s12672-024-01509-9</doi><tpages>21</tpages><orcidid>https://orcid.org/0000-0003-4861-2594</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2730-6011
ispartof Discover. Oncology, 2024-11, Vol.15 (1), p.641-21, Article 641
issn 2730-6011
2730-6011
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8d5e526acefc487d87679755aee1f945
source Open Access: PubMed Central; Publicly Available Content Database
subjects Acids
Biodistribution
Brain cancer
Breast cancer
Cancer Research
Cancer therapies
Chemical bonds
Contrast agents
Drug delivery systems
Imaging agents
Integrated approach
Internal Medicine
Medicine
Medicine & Public Health
Molecular Medicine
Nanomedicine
Nanoparticles
Nanotheranostics
Oncology
Pancreatic cancer
Polyethylene glycol
Polymer-drug conjugates
Polymerization
Polymers
Precision medicine
Quantum dots
Radiotherapy
Review
Rheumatoid arthritis
Side effects
Surgical Oncology
Targeted drug delivery
Tomography
Vitamin B
title Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A24%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polymer-drug%20conjugates:%20revolutionizing%20nanotheranostic%20agents%20for%20diagnosis%20and%20therapy&rft.jtitle=Discover.%20Oncology&rft.au=Parashar,%20Ashish%20Kumar&rft.date=2024-11-11&rft.volume=15&rft.issue=1&rft.spage=641&rft.epage=21&rft.pages=641-21&rft.artnum=641&rft.issn=2730-6011&rft.eissn=2730-6011&rft_id=info:doi/10.1007/s12672-024-01509-9&rft_dat=%3Cproquest_doaj_%3E3126813773%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-5385c6632e50b582dc20a8f5aa3313d6e16c2cd6fa2e2bb1289e24255de8fd6a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3126813773&rft_id=info:pmid/39527173&rfr_iscdi=true